A detailed history of Exane Derivatives transactions in Agilent Technologies, Inc. stock. As of the latest transaction made, Exane Derivatives holds 32 shares of A stock, worth $4,355. This represents 0.0% of its overall portfolio holdings.

Number of Shares
32
Previous 911 96.49%
Holding current value
$4,355
Previous $120,000 97.5%
% of portfolio
0.0%
Previous 0.04%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 12, 2022

SELL
$112.71 - $135.93 $99,072 - $119,482
-879 Reduced 96.49%
32 $3,000
Q1 2022

Apr 22, 2022

SELL
$126.0 - $156.48 $154,728 - $192,157
-1,228 Reduced 57.41%
911 $120,000
Q4 2021

Jan 28, 2022

BUY
$147.95 - $164.3 $98,238 - $109,095
664 Added 45.02%
2,139 $341,000
Q3 2021

Oct 26, 2021

SELL
$147.58 - $179.28 $379,428 - $460,928
-2,571 Reduced 63.54%
1,475 $232,000
Q2 2021

Jul 28, 2021

BUY
$127.69 - $148.81 $229,203 - $267,113
1,795 Added 79.74%
4,046 $598,000
Q1 2021

Apr 30, 2021

SELL
$114.99 - $130.12 $108,320 - $122,573
-942 Reduced 29.5%
2,251 $286,000
Q4 2020

Jan 27, 2021

BUY
$100.01 - $119.3 $319,331 - $380,924
3,193 New
3,193 $378,000

Others Institutions Holding A

About AGILENT TECHNOLOGIES, INC.


  • Ticker A
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 296,040,992
  • Market Cap $40.3B
  • Description
  • Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatogra...
More about A
Track This Portfolio

Track Exane Derivatives Portfolio

Follow Exane Derivatives and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exane Derivatives, based on Form 13F filings with the SEC.

News

Stay updated on Exane Derivatives with notifications on news.